NorthSea Therapeutics Employee Directory
Biotechnology ResearchNorth Holland, Netherlands11-50 Employees
NorthSea Therapeutics is a clinical-stage biotechnology company focused on developing therapies for orphan metabolic, inflammatory, and fibrotic diseases, with an emphasis on rare liver conditions. It operates in the United States and Europe and is based in Amsterdam, North Holland, Netherlands. The company relies on a proprietary platform of structurally engineered fatty acids to generate novel drug candidates, with research including non-alcoholic steatohepatitis and related metabolic diseases, and it has received FDA Rare Pediatric Disease designation for SEFA-6179 in treating Intestinal Failure-Associated Liver Disease. Its target customers are patients affected by orphan metabolic and fibrotic diseases, particularly rare liver conditions, along with healthcare providers and researchers seeking new therapies. A recent development is the appointment of Pam Vig, Ph.D., as an independent board member, effective March 20, 2026.
1-888-653-2347 
support@leadiq.com 
